TY - JOUR AU - Celli, B. R. AU - MacNee, W. PY - 2004 DA - 2004// TI - Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper JO - Eur Respir J VL - 23 UR - https://doi.org/10.1183/09031936.04.00014304 DO - 10.1183/09031936.04.00014304 ID - Celli2004 ER - TY - CHAP PY - 2014 DA - 2014// BT - Global strategy for the diagnosis, management and prevention of Chronic Obstructive Pulmonary Disease ID - ref2 ER - TY - JOUR AU - Brusasco, V. PY - 2006 DA - 2006// TI - Reducing cholinergic constriction: the major reversible mechanism in COPD JO - Eur Respir Rev VL - 15 UR - https://doi.org/10.1183/09059180.00009902 DO - 10.1183/09059180.00009902 ID - Brusasco2006 ER - TY - JOUR AU - Cazzola, M. AU - Molimard, M. PY - 2010 DA - 2010// TI - The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD JO - Pulm Pharmacol Ther VL - 23 UR - https://doi.org/10.1016/j.pupt.2010.03.003 DO - 10.1016/j.pupt.2010.03.003 ID - Cazzola2010 ER - TY - JOUR AU - Mahler, D. A. AU - D’Urzo, A. AU - Bateman, E. D. AU - Ozkan, S. A. AU - White, T. AU - Peckitt, C. AU - Lassen, C. AU - Kramer, B. PY - 2012 DA - 2012// TI - Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison JO - Thorax VL - 67 UR - https://doi.org/10.1136/thoraxjnl-2011-201140 DO - 10.1136/thoraxjnl-2011-201140 ID - Mahler2012 ER - TY - JOUR AU - van der Molen, T. AU - Cazzola, M. PY - 2012 DA - 2012// TI - Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes JO - Prim Care Respir J VL - 21 UR - https://doi.org/10.4104/pcrj.2011.00102 DO - 10.4104/pcrj.2011.00102 ID - van der Molen2012 ER - TY - JOUR AU - van Noord, J. A. AU - Buhl, R. AU - Laforce, C. AU - Martin, C. AU - Jones, F. AU - Dolker, M. AU - Overend, T. PY - 2010 DA - 2010// TI - QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease JO - Thorax VL - 65 UR - https://doi.org/10.1136/thx.2010.139113 DO - 10.1136/thx.2010.139113 ID - van Noord2010 ER - TY - JOUR AU - Coleman, C. I. AU - Limone, B. AU - Sobieraj, D. M. AU - Lee, S. AU - Roberts, M. S. AU - Kaur, R. AU - Alam, T. PY - 2012 DA - 2012// TI - Dosing frequency and medication adherence in chronic disease JO - J Manag Care Pharm VL - 18 ID - Coleman2012 ER - TY - JOUR AU - Donohue, J. F. AU - Anzueto, A. AU - Brooks, J. AU - Mehta, R. AU - Kalberg, C. AU - Crater, G. PY - 2012 DA - 2012// TI - A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD JO - Respir Med VL - 106 UR - https://doi.org/10.1016/j.rmed.2012.03.012 DO - 10.1016/j.rmed.2012.03.012 ID - Donohue2012 ER - TY - JOUR AU - Hanania, N. A. AU - Feldman, G. AU - Zachgo, W. AU - Shim, J. J. AU - Crim, C. AU - Lettis, S. AU - Barnhart, F. AU - Haumann, B. PY - 2012 DA - 2012// TI - The efficacy and safety of the novel long-acting beta2 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial JO - Chest VL - 142 UR - https://doi.org/10.1378/chest.11-2231 DO - 10.1378/chest.11-2231 ID - Hanania2012 ER - TY - JOUR AU - Donohue, J. AU - Maleki-Yazdi, M. R. AU - Kilbride, S. AU - Mehta, R. AU - Kalberg, C. AU - Church, A. PY - 2013 DA - 2013// TI - Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD JO - Respir Med VL - 107 UR - https://doi.org/10.1016/j.rmed.2013.06.001 DO - 10.1016/j.rmed.2013.06.001 ID - Donohue2013 ER - TY - JOUR AU - Celli, B. AU - Crater, G. AU - Kilbride, S. AU - Mehta, R. AU - Tabberer, M. AU - Kalberg, C. J. AU - Church, A. PY - 2014 DA - 2014// TI - Once-daily umeclidinium/vilanterol 125/25 mcg in COPD: a randomized, controlled study JO - Chest VL - 145 UR - https://doi.org/10.1378/chest.13-1579 DO - 10.1378/chest.13-1579 ID - Celli2014 ER - TY - CHAP PY - 1996 DA - 1996// BT - ICH harmonised tripartite guideline: guideline for good clinical practice E6(R1) ID - ref13 ER - TY - CHAP PY - 2008 DA - 2008// BT - WMA Declaration of Helsinki - ethical principles for medical research involving human subjects ID - ref14 ER - TY - JOUR AU - Hankinson, J. L. AU - Odencrantz, J. R. AU - Fedan, K. B. PY - 1999 DA - 1999// TI - Spirometric reference values from a sample of the general U.S. population JO - Am J Respir Crit Care Med VL - 159 UR - https://doi.org/10.1164/ajrccm.159.1.9712108 DO - 10.1164/ajrccm.159.1.9712108 ID - Hankinson1999 ER - TY - JOUR AU - Hanania, N. AU - Donohue, J. AU - Make, B. PY - 2013 DA - 2013// TI - A long term safety study of arformoterol tartrate in the maintenance therapy of patients with moderate to severe COPD: incidence of adverse events JO - Am J Respir Crit Care Med VL - 187 ID - Hanania2013 ER - TY - JOUR AU - Donohue, J. F. AU - Hanania, N. A. AU - Sciarappa, K. A. AU - Goodwin, E. AU - Grogan, D. R. AU - Baumgartner, R. A. AU - Hanrahan, J. P. PY - 2008 DA - 2008// TI - Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance JO - Ther Adv Respir Dis VL - 2 UR - https://doi.org/10.1177/1753465808089455 DO - 10.1177/1753465808089455 ID - Donohue2008 ER - TY - JOUR AU - Donohue, J. F. AU - Hanania, N. A. AU - Fogarty, C. AU - Campbell, S. C. AU - Rinehard, M. AU - Denis-Mize, K. PY - 2008 DA - 2008// TI - Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial JO - Ther Adv Respir Dis VL - 2 UR - https://doi.org/10.1177/1753465808093934 DO - 10.1177/1753465808093934 ID - Donohue2008 ER - TY - JOUR AU - Make, B. AU - Hanania, N. AU - Donohue, J. PY - 2013 DA - 2013// TI - A long term safety study of arformoterol tartrate in the maintenance therapy of patients with moderate to severe COPD: evaluation of lung function JO - Am J Respir Crit Care Med VL - 187 ID - Make2013 ER - TY - JOUR AU - Donohue, J. AU - Hanania, N. AU - Make, B. AU - Curry, L. PY - 2013 DA - 2013// TI - A long term safety study of arformoterol tartrate in the maintenance therapy of patients with moderate to severe COPD: incidence of respiratory-related deaths and COPD exacerbation-related hospitalizations JO - Am J Respir Crit Care Med VL - 187 ID - Donohue2013 ER - TY - JOUR AU - Casaburi, R. AU - Mahler, D. A. AU - Jones, P. W. AU - Wanner, A. AU - San, P. G. AU - ZuWallack, R. L. AU - Menjoge, S. S. AU - Serby, C. W. AU - Witek, T. PY - 2002 DA - 2002// TI - A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease JO - Eur Respir J VL - 19 UR - https://doi.org/10.1183/09031936.02.00269802 DO - 10.1183/09031936.02.00269802 ID - Casaburi2002 ER - TY - JOUR AU - Chapman, K. R. AU - Rennard, S. I. AU - Dogra, A. AU - Owen, R. AU - Lassen, C. AU - Kramer, B. PY - 2011 DA - 2011// TI - Long-term safety and efficacy of indacaterol, a long-acting beta(2)-agonist, in subjects with COPD: a randomized, placebo-controlled study JO - Chest VL - 140 UR - https://doi.org/10.1378/chest.10-1830 DO - 10.1378/chest.10-1830 ID - Chapman2011 ER - TY - JOUR AU - Mahler, D. A. AU - Donohue, J. F. AU - Barbee, R. A. AU - Goldman, M. D. AU - Gross, N. J. AU - Wisniewski, M. E. AU - Yancey, S. W. AU - Zakes, B. A. AU - Rickard, K. A. AU - Anderson, W. H. PY - 1999 DA - 1999// TI - Efficacy of salmeterol xinafoate in the treatment of COPD JO - Chest VL - 115 UR - https://doi.org/10.1378/chest.115.4.957 DO - 10.1378/chest.115.4.957 ID - Mahler1999 ER - TY - JOUR AU - Decramer, M. AU - Anzueto, A. AU - Kerwin, E. AU - Kaelin, T. AU - Richard, N. AU - Crater, G. AU - Tabberer, M. AU - Harris, S. AU - Church, A. PY - 2014 DA - 2014// TI - Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials JO - Lancet Respir Med VL - 2 UR - https://doi.org/10.1016/S2213-2600(14)70065-7 DO - 10.1016/S2213-2600(14)70065-7 ID - Decramer2014 ER - TY - JOUR AU - Salpeter, S. R. PY - 2009 DA - 2009// TI - Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events? JO - Drugs VL - 69 UR - https://doi.org/10.2165/11318580-000000000-00000 DO - 10.2165/11318580-000000000-00000 ID - Salpeter2009 ER - TY - JOUR AU - Anthonisen, N. R. AU - Connett, J. E. AU - Enright, P. L. AU - Manfreda, J. PY - 2002 DA - 2002// TI - Hospitalizations and mortality in the Lung Health Study JO - Am J Respir Crit Care Med VL - 166 UR - https://doi.org/10.1164/rccm.2110093 DO - 10.1164/rccm.2110093 ID - Anthonisen2002 ER - TY - CHAP PY - 2009 DA - 2009// BT - FDA Briefing Document ID - ref27 ER - TY - CHAP PY - 2012 DA - 2012// BT - Medical reviews, aclidinium bromide ID - ref28 ER -